Effectiveness of the autumnal COVID-19 vaccine dose during the winter and summer waves of the 2023/24 season in Spain [0.03%]
西班牙2023/24年度冬季和夏季COVID-19疫情中秋季加强剂疫苗的有效性
Ayelén Rojas-Benedicto,Gloria Pérez-Gimeno,Jacobo Mendioroz et al.
Ayelén Rojas-Benedicto et al.
Background: We estimated vaccine effectiveness (VE) of the COVID-19 monovalent XBB.1.5 vaccine recommended in Spain in October 2023 for ≥60-year-olds against medically-attended COVID-19 and COVID-19 hospitalization, duri...
Birth order and influenza vaccination: a comparative study of behaviors and intentions between first-time and second-time Chinese parents [0.03%]
独生与非独生中国父母的流感疫苗接种行为和意愿之比较研究
Kan Chen,Zhexin Xu,Yi Zhou et al.
Kan Chen et al.
Background: This study investigates the impact of birth order on influenza vaccination behaviors and intentions among parents of children under 6 years of age, and identifies factors contributing to vaccination disparitie...
Montanide ISA-51: a promising adjuvant in cancer vaccine immunotherapy [0.03%]
新型癌症免疫治疗疫苗佐剂Montanide ISA-51研究进展
Liu Nan,Xiuli Zhang,Li Ziyi et al.
Liu Nan et al.
Introduction: Cancer vaccine immunotherapy has shifted from traditional cytotoxic treatments toward strategies aimed at enhancing anti-tumor immunity, offering new therapeutic possibilities. Montanide ISA-51, a water-in-o...
Correction [0.03%]
改正的方法
Published Erratum
Expert review of vaccines. 2025 Dec;24(1):944. DOI:10.1080/14760584.2025.2567718 2025
Correction [0.03%]
改正措施
Published Erratum
Expert review of vaccines. 2025 Dec;24(1):945. DOI:10.1080/14760584.2025.2567720 2025
Indirect comparison of the immunogenicity of 15-valent and 20-valent pneumococcal conjugate vaccines in children using a 2 + 1 schedule [0.03%]
使用2+1免疫程序在儿童中对15价和20价肺炎球菌结合疫苗进行免疫原性间接比较研究
Shahrul Mt-Isa,Justin R Chumbley,Matthew S Kelly et al.
Shahrul Mt-Isa et al.
Background: Clinical trials have compared new pneumococcal conjugative vaccines (PCVs; PCV15 and PCV20) to an established PCV (PCV13) in a routine 2 + 1 schedule. This study performed an indirect comparison of PCV15 vs. P...
Two decades of GSK rotavirus vaccine (RV1): a global analysis to estimate vaccination completion and deaths averted in children under 5 years [0.03%]
人用轮状病毒疫苗(RV1)的二十年：全球分析估算
Victoria Genovez,Olivia Berton,Stéphanie Barthès et al.
Victoria Genovez et al.
Background: Rotavirus vaccination plays a key role in reducing rotavirus gastroenteritis (RVGE) related deaths. This analysis estimated the number of children under 5 years of age fully vaccinated with GSK rotavirus vacci...
The public health and economic impact of the Greek pediatric national immunization program [0.03%]
希腊儿童国家免疫计划的公共卫生和经济影响
Ilias Gountas,Sandra E Talbird,Justin Carrico et al.
Ilias Gountas et al.
Background: Vaccines are one of the most effective healthcare tools to prevent morbidity and mortality from infectious diseases. Research design and metho...
Pneumococcal vaccination willingness and influencing factors among older adults in Chongqing, China: a cross-sectional study based on the WHO's behavioral and social drivers of vaccination framework [0.03%]
基于世卫组织的疫苗接种行为和社会驱动因素框架下的中国重庆市老年人肺炎球菌疫苗接种意愿及影响因素：一项横断面研究
Jule Yang,Yanlin Cao,Luzhao Feng et al.
Jule Yang et al.
Background: In the context of China's rapidly aging population and persistently low pneumococcal vaccine coverage, this study applied the Behavioral and Social Drivers (BeSD) framework to investigate the willingness and d...
Sarah Murphy,Anna Kelly,Dominic F Kelly
Sarah Murphy
Introduction: The World Health Organisation (WHO) introduced the Expanded Programme on Immunisation (EPI) in 1974 to reduce morbidity and mortality from a range of vaccine-preventable infectious diseases including pertuss...